| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 39.75 | 4.4% | 4.7% |
| Total Income | 39.75 | 4.4% | 4.7% |
| Expenditure | 10.03 | 74.2% | 74.1% |
| PBT | — | ||
| Net Profit | 63.29 | 8538.7% | 8011.3% |
| OPM | 74.75% | ||
| NPM | 100.00% | 101.97pp | 102.11pp |
| EPS | 4.78 | 8066.7% | 47900.0% |
Chiron Real Estate Inc. Announces Second Quarter 2026 Financial Results
06 Aug 2026 · 6 Aug, 2:44 am
Summary
Chiron Real Estate Inc. reported a significant turnaround in net income for the second quarter of 2026, with net income attributable to common stockholders reaching $63.3 million ($4.78 per diluted share), compared to a net loss in the prior year period. Funds from operations (FFO) were $0.88 per share and Core FFO were $1.04 per share, both lower than the prior year. The company made strategic progress by completing its first Seniors Housing Operating Portfolio (SHOP) acquisitions totaling $249 million and selling a portfolio of IRFs for $217 million. Management highlighted meaningful progress in active capital allocation, portfolio repositioning, and building capabilities for future growth.
Key Highlights
- 1
Chiron Real Estate Inc. reported quarterly net income attributable to common stockholders of $63.3 million, or $4.78 per diluted share, for the three months ended June 30, 2026, a significant improvement from a net loss of $0.8 million, or $0.06 per diluted share, in the comparable prior year period.
- 2
Quarterly funds from operations (FFO) attributable to common stockholders and noncontrolling interest were $0.88 per share and unit for Q2 2026, compared to $0.98 per share and unit in the prior year period.
- 3
Core funds from operations (Core FFO) attributable to common stockholders and noncontrolling interest were $1.04 per share and unit for Q2 2026, down from $1.14 per share and unit in the comparable prior year period.
- 4
Same-property cash net operating income (Same-Property Cash NOI) growth for the Outpatient Medical portfolio was +0.8% on a year-over-year basis for the second quarter, with growth of +1.7% excluding a one-time revenue recovery in the prior year period.
- 5
The Company completed its inaugural SHOP acquisitions in June 2026, acquiring two newly-constructed luxury seniors housing communities for an aggregate purchase price of $249 million.
- 6
Chiron completed the sale of seven Inpatient Rehabilitation Facilities (IRFs) in June 2026 to a joint venture for $217 million, retaining a 15% equity interest.
- 7
During the second quarter, the Company issued $100 million of its 6.00% Series C Convertible Perpetual Preferred stock.
Management Comments
Mark Decker
Jr.
When we outlined our priorities earlier this year, we committed to active capital allocation, portfolio repositioning, and building the capabilities necessary to support our next phase of growth. During the second quarter, we made meaningful progress on each objective. We completed our inaugural SHOP acquisitions, monetized legacy assets at attractive valuations, strengthened our leadership team, and continued to redeploy capital into investments that we believe offer superior long-term return potential. While there is still work ahead, we believe the actions we've taken over the last several months have positioned Chiron as a stronger, more capable, and more relevant healthcare real estate company.
Informational and educational content only. Not investment advice.